Live Feed

6-K - DR REDDYS LABORATORIES LTD (0001135951) (Filer)

6-K - NOMURA HOLDINGS INC (0001163653) (Filer)

20-F - NOMURA HOLDINGS INC (0001163653) (Filer)

6-K - Lloyds Banking Group plc (0001160106) (Filer)

11-K - Zoetis Inc. (0001555280) (Filer)

New nonprofit research and development lab brings together a group of senior technical contributors from the Ethereum Foundation to ready the network for step-function wave of adoption from institutions, agentic finance and DeFi Ethlabs to reinforce foundational commitments to credible neutrality, censorship resistance and security New York, June 22, 2026 (GLOBE NEWSWIRE) -- A coordinated group of Ethereum ecosystem stewards today announced the launch of Ethlabs, an independent, nonprofit research and development organization formed to ready Ethereum for the next phase of institutional adoption. The funding effort is led by Bitmine Immersion Technologies, Inc. (NYSE:BMNR), Sharplink, Inc

DEF 14A - Professional Diversity Network, Inc. (0001546296) (Filer)

6-K - Draganfly Inc. (0001786286) (Filer)

 The expanded partnership places Check Point among a select group of security vendors cleared to bring OpenAI's defensive AI into the tools enterprises use every day REDWOOD CITY, Calif., June 22, 2026 /PRNewswire/ -- Check Point® Software Technologies Ltd. (NASDAQ:CHKP), a pioneer and global leader of cyber security solutions, today announced the use of OpenAI's frontier cyber capabilities into its customer-facing defenses. Through the OpenAI Daybreak Cyber Partner Program, open to only a select group of security vendors, Check Point can embed OpenAI models directly into the products, workflows, and managed services its customers rely on. 

COLUMBIA, Md., June 22, 2026 (GLOBE NEWSWIRE) -- Tenable® Holdings, Inc. (NASDAQ:TENB), the exposure management company, today announced it is working with OpenAI as part of the OpenAI Daybreak Cyber Partner Program. The collaboration brings together OpenAI's frontier AI capabilities, including GPT-5.5, and Tenable's leadership in exposure management to help organizations better understand cyber risk, prioritize action and stay ahead of attackers through Tenable product and service workflows. The announcement comes as AI is reshaping the threat landscape. Attackers are already using AI to accelerate reconnaissance, automate vulnerability discovery and compress the window between exposure

6-K - SILVERCORP METALS INC (0001340677) (Filer)

144 - MARA Holdings, Inc. (0001507605) (Subject)

F-1/A - Ruanyun Edai Technology Inc. (0001873454) (Filer)

Packaging Corporation of America (NYSE:PKG) will hold a conference call on Thursday, July 23, 2026, at 9:00 a.m. Eastern Time to discuss second quarter 2026 results. The conference call leader will be Mark Kowlzan. Second quarter earnings results will be released after the market closes on Wednesday, July 22, 2026. To access the conference call, you may pre-register for the conference by navigating to https://dpregister.com/sreg/10205355/102fb95d496. Once you have registered, you will receive your dial-in number. When dialing in the day of the call, please ask to join the Packaging Corporation of America earnings call. If you prefer not to pre-register, you may dial in the day of the ca

4 - Vision Marine Technologies Inc. (0001813783) (Issuer)

Awards celebrate a decade of network excellence and ten Opensignal accolades in latest reportTORONTO, June 22, 2026 /CNW/ - TELUS is celebrating recognition as Canada's most-awarded wireless network ever by Opensignal — a milestone that reflects the company's commitment to delivering reliable, superior network services and  world-class customer experiences. Under Darren's leadership, TELUS has set a new benchmark for Canadian telecommunications, dominating Opensignal's February 2026 report with ten top honours across critical performance categories. TELUS has won more Opensignal network awards than any other Canadian provider s

REDEMPLO is the first and only authorised treatment for adults with FCS that does not require genetic confirmation of the conditionPeople living with FCS have extremely high triglyceride levels and a substantially higher risk of acute pancreatitis and related long-term complications, reducing their quality of lifeMarketing authorisation is supported by positive Phase 3 PALISADE study data, in which 25 mg REDEMPLO demonstrated an 80% reduction in triglycerides from baseline and an 83% reduction in the incidence of acute pancreatitis in a pooled analysis of patients using all doses of REDEMPLO compared with placeboArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that the European

11-K - PLUMAS BANCORP (0001168455) (Filer)

6-K - TURKCELL ILETISIM HIZMETLERI A S (0001071321) (Filer)

6-K - RYANAIR HOLDINGS PLC (0001038683) (Filer)